Genovis AB (publ.) Management

Management criteria checks 4/4

Genovis AB (publ.)'s CEO is Fredrik Olsson, appointed in May 2015, has a tenure of 8.83 years. total yearly compensation is SEK2.69M, comprised of 58.9% salary and 41.1% bonuses, including company stock and options. directly owns 0.24% of the company’s shares, worth SEK5.05M. The average tenure of the management team and the board of directors is 2.2 years and 3.8 years respectively.

Key information

Fredrik Olsson

Chief executive officer

kr2.7m

Total compensation

CEO salary percentage58.9%
CEO tenure8.8yrs
CEO ownership0.2%
Management average tenure2.2yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

Is Now The Time To Look At Buying Genovis AB (publ.) (STO:GENO)?

Mar 18
Is Now The Time To Look At Buying Genovis AB (publ.) (STO:GENO)?

What You Can Learn From Genovis AB (publ.)'s (STO:GENO) P/EAfter Its 25% Share Price Crash

Feb 28
What You Can Learn From Genovis AB (publ.)'s (STO:GENO) P/EAfter Its 25% Share Price Crash

We Think That There Are Issues Underlying Genovis AB (publ.)'s (STO:GENO) Earnings

Feb 22
We Think That There Are Issues Underlying Genovis AB (publ.)'s (STO:GENO) Earnings

These Analysts Just Made A Huge Downgrade To Their Genovis AB (publ.) (STO:GENO) EPS Forecasts

Feb 20
These Analysts Just Made A Huge Downgrade To Their Genovis AB (publ.) (STO:GENO) EPS Forecasts

Genovis AB (publ.) (STO:GENO) Analysts Are More Bearish Than They Used To Be

Feb 04
Genovis AB (publ.) (STO:GENO) Analysts Are More Bearish Than They Used To Be

Here's Why Genovis AB (publ.) (STO:GENO) Has Caught The Eye Of Investors

Oct 06
Here's Why Genovis AB (publ.) (STO:GENO) Has Caught The Eye Of Investors

Are Genovis AB (publ.) (STO:GENO) Investors Paying Above The Intrinsic Value?

Jun 22
Are Genovis AB (publ.) (STO:GENO) Investors Paying Above The Intrinsic Value?

What Does Genovis AB (publ.)'s (STO:GENO) Share Price Indicate?

May 13
What Does Genovis AB (publ.)'s (STO:GENO) Share Price Indicate?

Do Genovis AB (publ.)'s (STO:GENO) Earnings Warrant Your Attention?

Dec 22
Do Genovis AB (publ.)'s (STO:GENO) Earnings Warrant Your Attention?

Should You Think About Buying Genovis AB (publ.) (STO:GENO) Now?

Nov 14
Should You Think About Buying Genovis AB (publ.) (STO:GENO) Now?

If EPS Growth Is Important To You, Genovis AB (publ.) (STO:GENO) Presents An Opportunity

Jul 08
If EPS Growth Is Important To You, Genovis AB (publ.) (STO:GENO) Presents An Opportunity

Is There An Opportunity With Genovis AB (publ.)'s (STO:GENO) 43% Undervaluation?

Jun 01
Is There An Opportunity With Genovis AB (publ.)'s (STO:GENO) 43% Undervaluation?

Genovis AB (publ.)'s (STO:GENO) Popularity With Investors Under Threat As Stock Sinks 27%

May 10
Genovis AB (publ.)'s (STO:GENO) Popularity With Investors Under Threat As Stock Sinks 27%

One Analyst Just Shaved Their Genovis AB (publ.) (STO:GENO) Forecasts Dramatically

Feb 10
One Analyst Just Shaved Their Genovis AB (publ.) (STO:GENO) Forecasts Dramatically

Is Now The Time To Put Genovis AB (publ.) (STO:GENO) On Your Watchlist?

Aug 09
Is Now The Time To Put Genovis AB (publ.) (STO:GENO) On Your Watchlist?

What Is Genovis AB (publ.)'s (STO:GENO) Share Price Doing?

Mar 27
What Is Genovis AB (publ.)'s (STO:GENO) Share Price Doing?

How Does Genovis AB (publ.)'s (STO:GENO) CEO Pay Compare With Company Performance?

Dec 30
How Does Genovis AB (publ.)'s (STO:GENO) CEO Pay Compare With Company Performance?

Is Now An Opportune Moment To Examine Genovis AB (publ.) (STO:GENO)?

Nov 23
Is Now An Opportune Moment To Examine Genovis AB (publ.) (STO:GENO)?

CEO Compensation Analysis

How has Fredrik Olsson's remuneration changed compared to Genovis AB (publ.)'s earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

kr62m

Sep 30 2023n/an/a

kr54m

Jun 30 2023n/an/a

kr57m

Mar 31 2023n/an/a

kr42m

Dec 31 2022kr3mkr2m

kr11m

Sep 30 2022n/an/a

kr41m

Jun 30 2022n/an/a

kr36m

Mar 31 2022n/an/a

kr36m

Dec 31 2021kr2mkr1m

kr25m

Sep 30 2021n/an/a

kr11m

Jun 30 2021n/an/a

kr12m

Mar 31 2021n/an/a

kr9m

Dec 31 2020kr3mkr2m

kr6m

Sep 30 2020n/an/a

-kr3m

Jun 30 2020n/an/a

kr3m

Mar 31 2020n/an/a

kr6m

Dec 31 2019kr3mkr2m

kr10m

Sep 30 2019n/an/a

kr12m

Jun 30 2019n/an/a

kr5m

Mar 31 2019n/an/a

kr1m

Dec 31 2018kr2mkr1m

-kr2m

Sep 30 2018n/an/a

-kr4m

Jun 30 2018n/an/a

-kr6m

Mar 31 2018n/an/a

-kr7m

Dec 31 2017kr1mkr1m

-kr8m

Compensation vs Market: Fredrik's total compensation ($USD253.33K) is below average for companies of similar size in the Swedish market ($USD434.58K).

Compensation vs Earnings: Fredrik's compensation has been consistent with company performance over the past year.


CEO

Fredrik Olsson (52 yo)

8.8yrs

Tenure

kr2,691,831

Compensation

Mr. Fredrik Olsson has been the Chief Executive Officer of Genovis AB since May 05, 2015 and also serves as its President. Mr. Olsson served as President of Genovis AB since May 05, 2015 until June 29, 201...


Leadership Team

NamePositionTenureCompensationOwnership
Fredrik Olsson
President & CEO8.8yrskr2.69m0.24%
SEK 5.0m
Magnus Langberg
Group Chief Financial Officer2.2yrsno data0.010%
SEK 217.7k
Susanne Ahlberg
General Counselno datano data0.096%
SEK 2.0m
Rikke Rytter
Vice President of Sales & Marketing2.2yrsno data0.012%
SEK 252.3k
Maria Edholm
Controllerno datano datano data
John Lindsay
President of Genovis Inc.no datano datano data

2.2yrs

Average Tenure

54yo

Average Age

Experienced Management: GENO's management team is considered experienced (2.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Torben Jorgensen
Independent Chairman of the Board3.8yrskr330.63k0.15%
SEK 3.2m
Charlotta Ljungqvist
Independent Director4.8yrskr197.13k0.0079%
SEK 167.7k
Mikael Lonn
Director10.2yrskr165.32k16.02%
SEK 340.9m
Magnus Gustafsson
Independent Director1.8yrskr98.57k0.0076%
SEK 162.6k
Steve Jordan
Independent Director2.8yrskr150.00kno data

3.8yrs

Average Tenure

70yo

Average Age

Experienced Board: GENO's board of directors are considered experienced (3.8 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.